JN9-56822-18871
2 vaccinations
5 coded responses
21 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 064 / CT
- Registered
- 2021-08-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-24
Dose 1 — Pfizer-BioNTech
-
2021-08-25
Registered in v-safe
- 2021-08-25
- 2021-08-27
- 2021-08-28
- 2021-08-29
- 2021-08-30
- 2021-08-31
- 2021-09-07
-
2021-09-14
Dose 2 — Pfizer-BioNTech
-
2021-09-15
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: No appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-18
- 2021-09-19
- 2021-09-21
- 2021-09-28
- 2021-10-05
-
2021-10-12
Survey response — day 28, dose 2MedDRA: Abdominal pain upper, Dizziness, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache, stomachache, dizzy.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Survey response — day 35, dose 2MedDRA: Dysmenorrhoea — Feeling: FairFree text: Extreme menstrual cramps.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-26
- 2021-12-14
-
2022-03-15
Survey response — 6 months, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Miscarriage · Healthcare visit (other): BloodworkMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-24 | Pfizer-BioNTech | No |
| 2 | 2021-09-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-16 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): No appetite
Release 10 — day 28, dose 2
Symptoms: Headache, stomachache, dizzy.
Release 10 — day 35, dose 2
Symptoms: Extreme menstrual cramps.
Release 11 — 6 months, dose 2
Symptoms: Fatigue
Release 12 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release